Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown3
Active Not Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT06302725Not ApplicableActive Not Recruiting

Vaginal Self-sampling for Detecting High-risk Human Papillomavirus Cervical Infection in Patients With Immune-mediated Inflammatory Diseases

NCT05509075UnknownPrimary

Nutraceuticals and Functional Foods

NCT05247099Unknown

Pediatric Eye Care Investigated Team

NCT04530461Unknown

Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases

Showing all 4 trials

Research Network

Activity Timeline